WO2010068897A3 - Stem cell enhanced protein products and uses thereof - Google Patents

Stem cell enhanced protein products and uses thereof Download PDF

Info

Publication number
WO2010068897A3
WO2010068897A3 PCT/US2009/067721 US2009067721W WO2010068897A3 WO 2010068897 A3 WO2010068897 A3 WO 2010068897A3 US 2009067721 W US2009067721 W US 2009067721W WO 2010068897 A3 WO2010068897 A3 WO 2010068897A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein products
stem cell
enhanced protein
cell enhanced
methods
Prior art date
Application number
PCT/US2009/067721
Other languages
French (fr)
Other versions
WO2010068897A2 (en
Inventor
Kedar Challakere
Original Assignee
Kedar Challakere
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kedar Challakere filed Critical Kedar Challakere
Priority to US13/133,786 priority Critical patent/US20110301249A1/en
Publication of WO2010068897A2 publication Critical patent/WO2010068897A2/en
Publication of WO2010068897A3 publication Critical patent/WO2010068897A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0601—Invertebrate cells or tissues, e.g. insect cells; Culture media therefor

Abstract

Methods for producing in-vitro cultured protein products that are enhanced with stem cells are disclosed. In-vitro cultured protein product compositions produced by said methods are also disclosed. The present invention also discloses methods of providing nutrients to an animal by feeding said animal with said in-vitro cultured protein products.
PCT/US2009/067721 2008-12-12 2009-12-11 Stem cell enhanced protein products and uses thereof WO2010068897A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/133,786 US20110301249A1 (en) 2008-12-12 2009-12-11 Stem cell enhanced protein products and uses therof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12199008P 2008-12-12 2008-12-12
US61/121,990 2008-12-12

Publications (2)

Publication Number Publication Date
WO2010068897A2 WO2010068897A2 (en) 2010-06-17
WO2010068897A3 true WO2010068897A3 (en) 2010-08-26

Family

ID=41508932

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/067721 WO2010068897A2 (en) 2008-12-12 2009-12-11 Stem cell enhanced protein products and uses thereof

Country Status (2)

Country Link
US (1) US20110301249A1 (en)
WO (1) WO2010068897A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111154726A (en) 2013-10-30 2020-05-15 密苏里大学的策展人 Scalable skeletal muscle lineage specification and breeding method
WO2015157163A1 (en) * 2014-04-07 2015-10-15 Rush University Medical Center Screening assay for choice of prebiotic to prevent/treat gastrointestinal and systemic diseases
US10485259B2 (en) 2015-03-27 2019-11-26 Kedarnath Krishnamurthy Challakere Synthetic avian-free egg white substitute and method of making same
US20200080050A1 (en) 2016-07-11 2020-03-12 Yaakov Nahmias Systems and methods for growing cells in vitro
WO2018189738A1 (en) 2017-04-09 2018-10-18 Supermeat The Essence Of Meat Ltd. Cultured meat-containing hybrid food
EP3638777A4 (en) 2017-07-13 2021-05-12 Memphis Meats, Inc. Compositions and methods for increasing the efficiency of cell cultures used for food production
WO2019078587A1 (en) * 2017-10-18 2019-04-25 서울대학교 산학협력단 Composition containing, as active ingredient, culture of chicken bone marrow-derived osteochondral progenitor cells for promoting osteogenesis or inducing chondrogenic differentiation
KR102094733B1 (en) * 2017-10-18 2020-03-30 서울대학교산학협력단 A composition comprising chick bone marrow derived osteochondroprogenitor cell culture as an active ingredient for inducing differentiation of stem cells into chondrocytes
US20230067465A1 (en) * 2021-09-02 2023-03-02 Danagreen Co., Ltd. Porous cell support containing plant protein and cultured meat prepared using the same
CA3231125A1 (en) 2021-10-19 2023-04-27 Joshua MARCH Plant base/animal cell hybrid meat substitute

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GRAYSON WARREN L ET AL H GRACE ET AL: "Effects of Initial Seeding Density and Fluid Perfusion Rate on Formation of Tissue-Engineered Bone", TISSUE ENGINEERING PART A, vol. 14, no. 11, November 2008 (2008-11-01), pages 1809 - 1820, XP002563990, ISSN: 1937-3341 *
HANNOUCHE D ET AL: "Engineering of implantable cartilaginous structures from bone marrow-derived mesenchymal stem cells", TISSUE ENGINEERING, vol. 13, no. 1, January 2007 (2007-01-01), pages 87 - 99, XP002563992, ISSN: 1076-3279 *
LIN ZHEN ET AL: "The chondrocyte: Biology and clinical application", TISSUE ENGINEERING, vol. 12, no. 7, July 2006 (2006-07-01), pages 1971 - 1984, XP002563991, ISSN: 1076-3279 *

Also Published As

Publication number Publication date
WO2010068897A2 (en) 2010-06-17
US20110301249A1 (en) 2011-12-08

Similar Documents

Publication Publication Date Title
WO2010068897A3 (en) Stem cell enhanced protein products and uses thereof
WO2013029013A8 (en) Enzyme producing bacillus strains
MX2009009371A (en) Enhanced production of fatty acid derivatives.
MX2011013700A (en) Talaromyces strains and enzyme compositions.
WO2010120785A3 (en) Methods and compositions for stem cell cultures
MX344588B (en) Production of fatty acids and derivatives thereof.
EP3623465A3 (en) Production of fatty acids and derivatives thereof
WO2011100477A3 (en) Antibodies and processes for preparing the same
WO2010014632A3 (en) Methods and compositions for improving the production of products in microorganisms
WO2010048417A3 (en) Perfusion bioreactors, cell culture systems, and methods for production of cells and cell-derived products
MY156588A (en) Systems using cell culture for production of isoprene
WO2012135805A3 (en) Delivery and formulation of engineered nucleic acids
WO2011091350A3 (en) Methods & compositions for improving protein production
WO2010096588A3 (en) Cell culture media containing combinations of proteins
WO2013010090A3 (en) Algal lipid compositions and methods of preparing and utilizing the same
GB2463337A (en) Methods of producing organic products with photosynthetic organisms and products and compositions thereof
WO2010014631A3 (en) Methods and compositions for improving the production of products in microorganisms
WO2007082693A8 (en) Improved enzyme formulations for animal feed
WO2012098537A8 (en) Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
MX2012004677A (en) Modified oil encapsulating proteins and uses thereof.
SG10201803982TA (en) Antibodies and processes for preparing the same
WO2014093505A3 (en) Acp-mediated production of fatty acid derivatives
MY182946A (en) Production of organic acids by fermentation at low ph
MX336787B (en) Genetically engineered microorganisms comprising 4-hydroxybenzoly-coa thioesterases and methods of using the same for producing free fatty acids and fatty acid derivatives.
EP3666900A3 (en) Cell-based production of nonulosonates

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09768591

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 13133786

Country of ref document: US

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 12/10/2011)

122 Ep: pct application non-entry in european phase

Ref document number: 09768591

Country of ref document: EP

Kind code of ref document: A2